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Mouse kidney expresses mRNA of four highly related sodium-
glucose cotransporters: Regulation by cadmium.
Background. To study the molecular mechanism responsible
for cadmium-induced Fanconi syndrome, an in vitro mouse model
has been used. We have previously shown that exposure of pri-
mary cultures of kidney cortical cells to micromolar concentra-
tions of cadmium inhibited uptake of the glucose analog, [14C]
methyl -d-glucopyranoside (AMG) (261 mCi/mmol, NEN),
and decreased mRNA levels of two kidney sodium-glucose
cotransporters (SGLTs), SGLT1 and SGLT2. We also isolated
partial cDNA of another member of the SGLT family, SGLT3-b,
from cultured kidney cells and observed that cadmium expo-
sure increased the abundance of its mRNA. In this study, we
investigated the effect of cadmium on the second mouse kidney
SGLT3 isoform, SGLT3-a. We also examined which SGLTs
were transcribed in vivo.
Methods. Cadmium was added to the confluent primary cul-
tures of kidney cortical cells at concentrations of 5, 7.5, and
10 mol/L. After 24 hours, uptake of [14C]AMG was measured
and total RNA was extracted for semiquantitative reverse tran-
scription-polymerase chain reaction (RT-PCR) of SGLT3-a.
Also, cDNA from whole kidneys of mice was used in PCR
with primers specific for each SGLT. A partial cDNA sequence
of SGLT3-a and the full-length cDNA sequence of SGLT3-b
were obtained from their respective PCR clones.
Results. Exposure of cortical cells to 5 mol/L cadmium
increased SGLT3-a mRNA level 3.4-  0.78-fold (mean 
SEM, P 0.03, N 5). mRNAs of SGLT1, SGLT2, SGLT3-a,
and SGLT3-b were simultaneously present in cDNA samples
from whole kidneys of mice. SGLT3-b cDNA sequence was
revised from its predicted sequence to encode a 660 amino
acid protein.
Conclusion. Reabsorption of glucose in mouse kidney may
involve four SGLTs. Cadmium affects mRNA expression of
all four SGLTs in vitro.
Chronic exposure to cadmium by ingestion of contami-
nated food and water or by inhalation of metal dust leads
to accumulation of this metal in kidney [1]. Kidney injury
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caused by cadmium is manifested by impaired reabsorp-
tion of essential nutrients from the glomerular filtrate
and clinical findings of glucosuria, tubular proteinuria,
aminoaciduria, and hyperphosphaturia.
The reabsorptive process by which glucose is trans-
ported from the glomerular filtrate back into the blood
stream involves secondary active transport and facilitated
diffusion [2]. At the luminal surface, the electrochemical
potential gradient of Na drives uptake of glucose into
tubular epithelial cells and is considered to involve two
apical sodium-glucose cotransporters (SGLTs): a low-
affinity, high-capacity transporter, SGLT2, and a high-
affinity, low-capacity transporter, SGLT1. SGLT2 pro-
teins in the early segments of proximal tubules are thought
to perform the bulk transfer of glucose into cells. Resid-
ual glucose is scavenged from the tubular fluid by SGLT1
in later segments of the proximal nephron. Following
absorption into tubule cells, glucose is transported back
to the blood stream by facilitated diffusion via basolat-
eral glucose cotransporters known as GLUTs. The elec-
trochemical potential gradient is restored when trans-
ported Na is returned to the blood stream via the
basolateral Na,K-ATPase.
In recent years, another member of SGLT family,
SGLT3, has been identified. SGLT3 cDNA was first iso-
lated from a pig kidney epithelial cell line, LLC-PK1,
and has also been variously designated as SAAT1 or
pSGLT2 [3, 4]. In mouse, analysis of the chromosome
10 DNA sequence had predicted two reverse-oriented
genes, Slc5a4a and Slc5a4b, encode SGLT3 homologous
proteins [5]. Studies on pig SGLT3 have shown that
this transporter has characteristics of both SGLT1 and
SGLT2. Expression of pig SGLT3 and human SGLT1
in Xenopus laevis oocytes demonstrated that SGLT1 af-
finity for glucose was 30-fold higher than the affinity of
SGLT3 for this sugar [6]. It was also shown that SGLT3
was more selective than SGLT1 in its sugar binding and
transport; unlike SGLT1, SGLT3 did not transport galac-
tose [6, 7]. The latter two features of SGLT3, low affinity
for glucose and no affinity for galactose, are similar to
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those of SGLT2 [8, 9]. The Na to glucose coupling
ratio is yet another distinguishing characteristic among
SGLTs. For SGLT1, this coupling ratio is two, whereas
SGLT2 couples one Na to one glucose molecule [8–10].
In that regard, with a stoichiometry of Na to glucose
coupling of 2:1, SGLT3 resembles SGLT1 [11].
To unravel the mechanism by which cadmium causes
glucosuria, we have been investigating the in vitro effects
of this metal on primary cultures of mouse kidney cortical
cells, particularly its effects on SGLTs. Following cadmium
exposure, mouse cortical tubule cell monolayers exhib-
ited decreased capacity to take up glucose. Exposure of
cells to increasing concentrations of cadmium resulted
in a decrease in methyl -d-glucopyranoside (AMG)
(261 mCi/mmol, NEN) uptake and coincided with a de-
creased maximum velocity (Vmax) of Na-dependent glu-
cose cotransport. However, the Michaelis constant (Km)
value for glucose remained unaltered [12–14]. Above
characteristics of cadmium effect on AMG uptake were
consistent with the loss of functional transporter(s). Inhi-
bition of glucose uptake was accompanied by a reduction
in the mRNA levels of SGLT1 and SGLT2 [15, 16]. In
addition, a partial cDNA of the SGLT3 isoform encoded
by the Slc5a4b gene was isolated from cultured mouse
kidney cells. It was found that its mRNA levels dramati-
cally increased in cells exposed to cadmium. In the pres-
ent study, this isoform is referred to as SGLT3-b and its
full-length cDNA sequence is shown. The deduced
amino acid sequence of full-length SGLT3-b suggests
that Slc5a4b encodes a 660 rather than the predicted 616
amino acid protein. This difference in length is due to
the presence of a previously unidentified nucleotide in
the cDNA sequence. In the current study, we isolated a
partial cDNA fragment of SGLT3-a, encoded by
Slc5a4a, and found that cadmium exposure resulted in
an increase in its mRNA level.
The physiologic importance of SGLT3 is supported
by showing, for the first time, that mRNAs of SGLT3-a
and SGLT3-b were simultaneously present together with
those of SGLT1 and SGLT2 in the whole mouse kidney.
The high degree of amino acid conservation among the
four mouse kidney SGLTs is suggestive of the idea that
the efficient reabsorption of essential nutrient glucose is
not limited to transport activities of SGLT1 and SGLT2
and that SGLT3 could play an important role in uptake
of glucose from glomerular filtrate. This proposed com-
plementary role of SGLT3 in uptake of glucose is further
strengthened by our observation that a reduction in the
levels of SGLT1 and SGLT2 mRNA in cells exposed to
cadmium was accompanied by an increase in the levels
of SGLT3-a and SGLT3-b mRNA.
METHODS
Materials
All cell culture materials, including the media, anti-
biotics, and CdCl2, were purchased from Sigma Chemical
Company (St. Louis, MO, USA). QIAGEN kits (Valen-
cia, CA, USA) were used to purify polymerase chain
reaction (PCR) reactions, to gel purify DNA fragments,
and to prepare total RNA or plasmid DNA. All primers
were synthesized by integrated DNA technology (IDT)
(Coralville, IA, USA). All amplification reactions were
carried out with 2.5 units of Platinum Taq DNA Polymer-
ase (Invitrogen, Carlsbad, CA, USA) in thermocycler
GeneAmp PCR System 9700 (PE Applied Biosystems,
Foster City, CA, USA).
Cell culture and AMG uptake
Cell culture conditions were the same as described be-
fore [16]. Briefly, cortical cells were isolated from kidneys
of 3- to 4-week-old C57Bl6 male mice. Cells were cul-
tured in 35 mm culture dishes in 50% Ham’s F-12 and
50% Dulbecco’s modified Eagle’s medium containing
appropriate antibiotics and supplements at 37C and 5%
CO2. CdCl2 was added to the near confluent cells at con-
centrations of 5, 7.5, or 10mol/L, and cells were cultured
for an additional 24 hours in the presence of cadmium.
Cells cultured in media alone were used as the controls.
For each condition tested, parallel culture plates were
prepared to measure the uptake of [14C]AMG, and to
prepare total RNA (see Semiquantification of SGLT3-a).
Sodium-dependent uptake of [14C]AMG was deter-
mined in control and cadmium-treated cells as described
before [16]. Uptake was carried out for 60 minutes in
monolayers of cells cultured under different experimen-
tal conditions in the presence of either sodium chloride
(three plates) or choline chloride (two plates). Following
termination of uptake, cells were washed and lysed in
Triton X-100/NaOH. Radioactivity was then measured
by liquid scintillation. Values for the sodium-dependent
and the sodium-independent uptakes of [14C]AMG were
averaged and the latter value was subtracted from the
former. The results were expressed as nmol AMG/g
DNA. A similar approach was used to measure sodium-
dependent uptake of b-d-glucosylisophosphoramide mus-
tard (D-19575). Both [14C]-labeled and unlabeled D-19575
were gifts of Baxter Oncology GmbH (Frankfurt am
Main, Germany).
Semiquantification of SGLT3-a
Total RNA from either control or cadmium-treated
cells was prepared as described before [15]. Total RNA
(3 g) was primed with 0.5 g of oligo(dT)12-18, and 50
units of Superscript II reverse transcriptase using Super-
script First-Strand Synthesis System for RT-PCR (In-
vitrogen) in a total volume of 20 L as described before
[15]. Forward (5-AGAAGTATCTCAAGGTGG-3)
and reverse (5-ATCAGCTCCGTTCTCCT-3) PCR
primers were designed based on the predicted mRNA
sequence of mouse Slc5a4a gene (GenBank accession
number AF251267). The above primers were used in
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Fig. 1. Semiquantification of sodium-glucose cotransporter SGLT3-a
mRNA in cadmium-treated cultured mouse kidney cortical cells. Mouse
renal cortical cells were cultured in 35 mm dishes at 37C and 5% CO2
in cadmium-free media until nearly confluent. Media containing either
5, 7.5, or 10 mol/L CdCl2 was then added and cells were incubated
for an additional 24 hours. Cells cultured in cadmium-free media served
as controls. (A) Sodium-dependent uptake of [14C] methyl -d-glucopy-
ranoside (AMG) at 60 minutes with increasing media cadmium concen-
tration expressed as percentage uptake of untreated cells. Bars represent
mean  SE (N  5). a represents a statistically significant difference
(P  0.005) between uptake in the presence of cadmium and control
(N  5). b represents a statistically significant difference (P  0.025)
between uptake at 7.5 and 10 mol/L cadmium and uptake at 5 mol/L.
(B ) Effect of cadmium on mRNA of SGLT3-a. Total RNA extracted
from parallel cultures of untreated or cadmium-exposed cells were
primed with oligo(dT)12-18 and reverse transcribed. Semiquantitative
polymerase chain reaction (PCR) was performed with specific primers
to SGLT3-a. [a represents a statistically significant difference (P 0.03)
between values from cadmium-treated cells and controls (N  5)]. (C)
Constitutively expressed S15 was used as internal control. A representa-
tive stained gel of each PCR is shown above the corresponding graphs;
numbers above the lanes indicate the micromolar concentration of
cadmium in the medium. Bars represent mean  SE of percentage
value of the untreated control.
amplification reactions with 2 L of cDNA from control
or cadmium-treated cells as templates in a total volume
of 50 L. All reactions were heated at 94C for 2 minutes
prior to amplification. Amplification was carried out by
either 40 or 43 cycles of 94C for 30 seconds, 55C for 30
seconds, and 72C for 55 seconds. Following amplification,
reactions were heated for an additional 5 minutes at 72C.
Amplification of a housekeeping gene, S15, encoding a
small ribosomal subunit protein was used as an internal
PCR control. The sequence of S15 primers and the PCR
conditions were described before [15]. Following ampli-
fication, 10 L of each PCR reaction was analyzed on
1.5% agarose gel containing 0.75 g/mL ethidium bro-
mide. Separated PCR products were documented and
quantified with the Kodak EDAS 290 System (Roches-
ter, NY, USA). The major PCR product with the ex-
pected size of 421 bp was gel purified from samples of
control and 10 mol/L cadmium-treated cells and its
DNA sequence was confirmed.
Amplification of SGLT1, SGLT2, SGLT3-a, and
SGLT3-b cDNA from whole kidney
Cultured mouse kidney cortical cells express mRNA
of SGLT1, SGLT2, SGLT3-a, and SGLT3-b [15] (Fig.
1). Next, we determined whether the mRNAs of the
above SGLTs were present in the whole kidneys of mice.
Kidneys were removed from C57Bl6 male mice under
anesthetic and total RNA was extracted using RNeasy
Mini Kit (QIAGEN). Briefly, kidneys were cut into small
pieces in the presence of denaturing buffer, and homoge-
nized using Fisher PCR Tissue Homogenizing Kit (Pitts-
burgh, PA, USA). The homogenate was then applied on
a QIAshredder column and the cleared lysate was loaded
on an RNeasy Mini column. Total RNA prepared as
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Table 1. Amplification primers and polymerase chain reaction (PCR) conditions of sodium-glucose transporters
SGLT3-a and SGLT3-b cDNA clones
Clone Primer Primer sequence (5→3) Extension time Insert size bp Primer source GenBank #
SGLT3-a (3) Forward AGAAGTATCTCAAGGTGG 55 seconds 663 AF251267
Reverse TATTGCTGTGGACGAGCT AC005818
SGLT3-b (5) Forward CAGAACCTCCTGAAG 2 minutes 1776 AF251268
Reverse CACCAGCTTCTTCTTGAGTT AF251268
SGLT3-b (3) Forward ATCAGAGAGAGAGAGCTCATGA 55 seconds 752 AF251268
Reverse GTTTCTGCTTCCTTC AK008500
A 2L aliquot of cDNA from cadmium-treated cells was used as template. All reaction mixtures were heated for 2 minutes at 94C prior to amplification. All amplification
included 45 cycles of 94C for 30 seconds, 55C for 30 seconds, and 72C for the time indicated in the table.
instructed by the manufacturer with an extra on-the-
column DNase I digestion step. cDNA synthesis was
carried out by priming 3g kidney total RNA with either
60 ng random hexamers or 0.5 g oligo(dT)12-18 and 50
units of Superscript II reverse transcriptase in a total
volume of 20 L using the Superscript First-Strand Syn-
thesis System for RT-PCR Kit and following the manu-
facturer’s instructions (Invitrogen).
For amplification, reactions were set up with 2 L
aliquots of kidney cDNA sample and the same primer
sets used for the semiquantification of each SGLT in
the cadmium experiments [15]. Prior to amplification,
reactions were heated to 94C for 2 minutes. SGLTs
were amplified by 45 cycles of 94C for 30 seconds, 55C
for 30 seconds, and 72C for 45 seconds. Following ampli-
fication, samples were heated for an additional 5 minutes
at 72C. To show the RNA origin of the amplified frag-
ments, parallel PCRs were set up with kidney cDNA
synthesis reactions in which reverse transcriptase enzyme
had been omitted. Sample of each SGLT PCR product
was purified and its DNA sequence was confirmed.
Partial SGLT3-a and full-length SGLT3-b
cDNA sequences
In mouse, genes Slc5a4a and Slc5a4b are located on
chromosome 10 and their chromosomal and predicted
mRNA sequences have been reported under GenBank
accession numbers AF251267 and AF251268, respectively.
The above sequence information was used to design am-
plification primers to obtain cDNA sequences of mouse
kidney SGLT3-a and SGLT3-b. Since exposure of mouse
kidney cortical cells to cadmium results in an increase in
the mRNA levels of SGLT3-a and SGLT3-b [15] (Fig. 1),
cDNA from cadmium-treated cells was used as the tem-
plate in the following amplification reactions. Table 1
describes the PCR primers and amplification conditions
used to obtain SGLT3 clones.
To amplify the 3 portion of SGLT3-a cDNA, the
forward primer was chosen so that it was within the
predicted coding region of SGLT3-a mRNA and was
identical to the forward primer used in semiquantitative
PCR of SGLT3-a described above. The reverse primer
was designed based on the chromosomal DNA sequence
of Slc5a4a flanking predicted stop codon of SGLT3-a
such that the terminal 3 nucleotide of this primer was
six nucleotides downstream of TGA codon of SGLT3-a.
PCR was carried out under conditions indicated in Table 1.
The amplified 663 bp 3 portion of SGLT3-a cDNA was
purified and cloned into pGEM-T Easy vector (Promega,
Madison, WI, USA). Double-stranded sequences of two
individual clones were determined and a consensus se-
quence was obtained. This sequence was submitted to the
GenBank under accession number AF498304. Multiple
attempts to amplify 5 portion of SGLT3-a cDNA had
been unsuccessful.
Full-length SGLT3-b cDNA could not be amplified
using primers immediately adjacent to its putative start
and stop codons. Therefore, to obtain full-length sequence
of SGLT3-b cDNA, we decided to PCR-amplify two
overlapping cDNA fragments encompassing both the
coding region and the respective flanking nucleotides.
In order to design primers for amplification of the 5
fragment of SGLT3-b, the predicted mRNA of Slc5a4b
was used (Table 1). The forward primer was designed
such that the terminal 3 nucleotide of this primer was
3 bp upstream of SGLT3-b putative start codon and the
reverse primer was located in its coding region. The
resulting 1776 bp PCR fragment was purified and cloned
into pGEM-T Easy vector. The double-stranded se-
quences of three individual SGLT3-b (5) clones were
determined and used to obtain a consensus sequence.
To amplify the 3 fragment of SGLT3-b, we designed
a forward primer whose sequence was located in the
coding region of Slc5a4b and a reverse primer designed
based on the sequence of a mouse small intestine clone
with the GenBank accession number AK008500. The
reverse primer was located six nucleotides downstream
of our proposed new stop codon of SGLT3-b (see Results
section). Following cloning of the resulting 752 bp PCR
product into pGEM-T Easy vector, three individual
SGLT3-b (3) clones were isolated, their double-stranded
sequences were determined, and a consensus sequence
was obtained.
Full-length sequence of SGLT3-b cDNA presented in
Figure 4A was obtained by assembling the concensus se-
quences of the 5 and the 3 fragments of SGLT3-b into
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one sequence. This full-length sequence of SGLT3-b re-
placed its previously reported partial sequence under
GenBank accession number AF411960 [15].
DNA sequencing and data analysis
Double-stranded sequences of the SGLT3-a (3) clone
as well as the SGLT3-b (5) and (3) clones were deter-
mined by Sequetech (Mountain View, CA, USA). Se-
quencing of other samples was performed by the Protein/
Nucleic Acid Facility at the Medical College of Wiscon-
sin. Unless otherwise stated, nucleotide and amino acid
analyses were performed using GCG SeqWeb programs
(Accelrys, Inc., Madison, WI, USA).
Statistical analysis of data was performed using Mini-
tab statistical software package release 13 (Minitab, Inc.,
State College, PA, USA). The result at each cadmium
concentration is the average of percent changes relative
to control values  SEM of five independent experi-
ments (culture groups). Data were analyzed by analysis
of variance (ANOVA) with metal concentration and
culture group as independent variables. Levels of signifi-
cance for comparisons of means was determined by the
method of Tukey with significance taken at P  0.05.
RESULTS
Semiquantification of SGLT3-a mRNA in cells
exposed to cadmium
Exposure of mouse kidney cortical cells in vitro to 5
to 10 mol/L cadmium results in a significant decrease
in uptake of the glucose analog, [14C]AMG, a decrease in
the mRNA levels of SGLT1 and SGLT2, and an increase
in the level of SGLT3-b mRNA [15]. In this study, we
expanded our investigation to the effect of this metal on
the level of SGLT3-a mRNA encoded by Slc5a4a gene.
Consistent with our previous observations, exposure
of kidney cortical cells to 5 to 10mol/L cadmium resulted
in a dose-dependent decrease in the uptake of AMG to
70% to 40% of the control untreated cells, respectively
(Fig. 1A). To quantify the effect of cadmium on SGLT3-a
mRNA levels in the cells, primers were made to the
predicted mRNA sequence of Slc5a4a. Figure 1B shows
the result of semiquantitative reverse transcription (RT)-
PCR analysis of SGLT3-a in cells exposed to cadmium.
Similar to its effect on SGLT3-b mRNA levels, cadmium
also stimulated the levels of SGLT3-a mRNA. Exposure
of cells to 5 to 10 mol/L cadmium for 24 hours resulted
in a 3.4  0.78 SEM-fold increase (P  0.03, N  5) in
SGLT3-a mRNA as compared to its level in controls.
To eliminate the possibility that cadmium exposure re-
sulted in a general stimulatory effect on cell mRNA, we
also measured the mRNA levels of the housekeeping
gene encoding small ribosomal subunit, S15. Figure 1C
shows that, at each cadmium concentration tested, S15
Fig. 2. Expression of sodium-glucose cotransporters SGLT1, SGLT2,
SGLT3-a, and SGLT3-b in whole mouse kidney. Total RNA was ex-
tracted from whole kidneys of mice and cDNA was prepared by priming
with random hexamers (SGLT1, SGLT2, and SGLT3-b) or priming
with oligo(dT)12-18 (SGLT3-a) and used as template in polymerase chain
reactions (PCRs). Abbreviations are: M, DNA molecular weight
marker; 1, SGLT-1; 2, SGLT2; 3-a, SGLT3-a; and 3-b, SGLT3-b.
mRNA levels remained unchanged from levels in un-
treated control cells.
Expression of SGLTs in the kidney
With amplification of SGLT3-a cDNA from primary
cultures of mouse kidney cortical cells (Fig. 1) and results
presented in our previous study [15], we have shown that
these cells simultaneously expressed mRNAs of the four
SGLT isoforms. It was decided to investigate whether
kidneys of normal mice expressed these four mRNA
species (Fig. 2). A cDNA of mouse kidney total RNA
synthesized using random hexamers provided an excel-
lent template for amplification of SGLT1, SGLT2, and
SGLT3-b. However, a PCR product of SGLT3-a was
obtained only when the same kidney RNA was synthe-
sized with oligo(dT) primer, instead.
Partial 3 cDNA sequence of SGLT3-a
Multiple attempts to PCR amplify the full-length cDNA
of kidney SGLT3-a were unsuccessful. Similarly, a strat-
egy to separately amplify the 5 and the 3 portions of
SGLT3-a and to assemble their respective sequences into
one failed because the 5 portion of SGLT3-a cDNA could
not be amplified. We were able to amplify a 0.6 kb 3
portion of SGLT3-a by using forward and reverse primers
to the internal coding region of Slc5a4a-predicted mRNA
and to the chromosomal DNA sequences six nucleotides
downstream of its predicted stop codon, respectively.
The nucleotide and deduced amino acid sequences of this
partial cDNA clone of SGLT3-a are shown in Figure 3.
Comparison of this SGLT3-a cDNA sequence with
Slc5a4a-predicted mRNA sequence showed that, with
an exception of one nucleotide, the two were identical.
This fragment of SGLT3-a encoded a reading frame of
206 amino acids and it included the previously suggested
stop codon of Slc5a4a. Deduced amino acid sequence of
SGLT3-a was identical to that of the C-terminal Q451
to A656 of the corresponding Slc5a4a predicted amino
acid sequence.
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Fig. 3. Nucleotide and deduced amino acid sequences of partial 3
cDNA of mouse kidney sodium-glucose cotransporter SGLT3-a. The
sequence of a 627 bp 3 portion of SGLT3-a (top row) was obtained
by polymerase chain reaction (PCR) amplification of cDNA from cad-
mium-exposed cultured mouse kidney cortical cells. Amplification prim-
ers were made to the predicted mRNA of Slc5a4a and the chromosomal
DNA sequence immediately downstream of the Slc5a4a-predicted stop
codon (Table 1). The cDNA sequence contained an open reading frame
encoding 206 amino acids (bottom row), which was identical in sequence
to amino acids 451 to 656 of Slc5a4a. *represents stop. Primer sequences
are not included in the cDNA sequence. Numbers to the left and the
right correspond to the nucleotide and amino acid sequences, respec-
tively.
Full-length cDNA sequence of SGLT3-b
A full-length cDNA fragment of SGLT3-b could not
be amplified, but we were able to obtain the full-length
cDNA sequence of SGLT3-b by amplifying and cloning
its overlapping 5 and 3 fragments. The consensus se-
quences of the 5 and the 3 clones were assembled into
one continuous sequence and shown in Figure 4A.
Initially, we used the predicted mRNA sequence of
Slc5a4b to design primers to amplify the 5 and 3 frag-
ments of SGLT3-b cDNA. Upon comparison of mouse
kidney SGLT3-b cDNA sequence with that of its pre-
dicted sequence, it was found that the two were basically
the same and shared more than 99% nucleotide sequence
identity (not shown). However, two major differences
between the kidney cDNA and the predicted mRNA
sequence of SGLT3-b were noticed. First, the three con-
secutive nucleotides “cag” at positions 1101 to 1103 of
Slc5a4b mRNA sequence were absent in the correspond-
ing region of SGLT3-b cDNA between adenine 1020
and cytosine 1021 (Fig. 4A, underlined nucleotides). This
difference resulted in an in-frame deletion of the corre-
sponding Ala341 of Slc5a4b from that of SGLT3-b.
To amplify the 3 fragment, the forward primer was
chosen in the coding region and the reverse primer was
designed such that it was located downstream of the
suggested stop codon of Slc5a4b (see Fig. 4A). Sequence
of the resulting 3 fragment of SGLT3-b clone was com-
pared to that of Slc5a4b, and upon detailed examination
of the aligned sequences, we noticed that the sequence
of Slc5a4b was missing an adenine nucleotide, which was
undoubtedly present in our SGLT3-b cDNA clone. As
shown in Figure 4A, this adenine is located at position
1771 of SGLT3-b (boxed nucleotide) in the correspond-
ing region between nucleotides 1853 and 1854 of Slc5a4b
predicted mRNA sequence. In addition, the GenBank
search identified three partial cDNA clones of mouse
small intestine with accession numbers AK008500, AK-
008368, and AK008310, which had identical sequences to
each other and to our SGLT3-b clone. Alignment of the
above sequences with SGLT3-b showed that they, too,
contained this extra adenine. Presence of this residue
results in a profound difference between the proteins
encoded by SGLT3-b cDNA and Slc5a4b-predicted
mRNA sequences. Addition of this adenine caused a
shift in the predicted reading frame so that the stop
codon of SGLT3-b cDNA became located 134 nucleo-
tides downstream from its predicted position in Slc5a4b
mRNA sequence (Fig. 4A, double underlined nucleo-
tides). Subsequently, another set of primers were de-
signed in order to amplify 3 fragment of SGLT3-b, which
contained its newly identified stop codon. The deduced
full-length amino acid sequence of SGLT3-b cDNA sug-
gested that Slc5a4b gene encoded a 660, rather than a
616, residue protein.
Figure 4B shows the predicted secondary structure of
SGLT3-b. SGLT3-b appears to have 14 transmembrane
helices (TMHs), an extracellular N-terminus, 6 extracel-
lular and 7 cytoplasmic loops, and a C-terminus ending
abruptly in the membrane. The predicted secondary
structure of SGLT3-a, deduced from sequence of Slc5a4a,
was identical to that of SGLT3-b (not shown).
Amino acid comparison of the four mouse kidney SGLTs
Figure 5 shows the amino acid sequence alignment of
the four mouse SGLTs. With the exception of the N- and
C-terminal regions, the four SGLTs exhibit remarkably
high degree of sequence conservation. SGLT2 appeared
to have the least homologous sequence. The overall simi-
larity between the full-length sequences of SGLT2 and
the other SGLTs was about 70%. Overall, SGLT1 was
more homologous to SGLT3-a and SGLT3-b than to
SGLT2. The similarity between SGLT3-b and either
SGLT3-a or SGLT1 was as high as 80%.
The divergent regions are mainly found at the N- and
C-terminal regions of SGLTs. The first 20 amino acids
of SGLT2 do not share any sequence homology with the
N-terminal sequences of the other SGLTs. In this region,
sequence conservation between isoforms of SGLT3 is
low and is less than 50%. Interestingly, while SGLT1
shares only 30% sequence similarity with SGLT3-a, a 70%
similarity exists between N-terminal sequences of SGLT1
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Fig. 4. Nucleotide and deduced amino acid sequences of full-length cDNA of mouse kidney sodium-glucose cotransporter SGLT3-b. (A) The
sequence of a 1990 bp full-length SGLT3-b cDNA sequence (top row) was obtained by cloning two overlapping polymerase chain reaction (PCR)
fragments of SGLT3-b amplified from cDNA of cadmium-exposed cultured mouse kidney cortical cells. Amplification primers were made to the
predicted mRNA of Slc5a4b and to cDNA of a mouse small intestine clone (Table 1). Nucleotides “cag” in the predicted mRNA of Slc5a4b were
absent from their corresponding positions between nucleotides 1020 and 1021 of SGLT3-b (underlined). The previously unidentified adenine
nucleotide at position 1771 is boxed. Existence of this nucleotide in the coding region of SGLT3-b resulted in a different open reading frame with
the stop codon (*) located 134 nucleotides downstream from its previously suggested position (double underlined). This revised open reading
frame encoded a 660 amino acid protein (bottom row) rather than the suggested 616. Primers are not included in the cDNA sequence. Numbers
to the left and the right correspond to the nucleotide and amino acid sequences, respectively. (B) The amino acid sequence of SGLT3-b was
analyzed for prediction of transmembrane helices (TMHs) by TMHMM (v. 2.0) program at http://www.cbs.dtu.dk. TMHs are shown as thick
rectangles, extracellular domains are shown as lines attached to the upper portions of TMHs, and cytoplasmic domains are lines attached to the
bottom portions of TMHs. Fourteen TMHs, extracellular N-terminus, 6 extracellular, and 7 cytoplasmic loops were predicted. Position of every
100 amino acids is marked. The predicted residues forming the TMHs of SGLT3-b are as follows: TMH1, 26-48; TMH2, 79-101; TMH3, 105-127;
TMH4, 147-169; TMH5, 179-201; TMH6, 208-227; TMH7, 274-291; TMH8, 312-334; TMH9, 380-402; TMH10, 423-445; TMH11, 455-477; TMH12,
484-506; TMH13, 526-548; TMH14, 640-659.
and SGLT3-b. At the C-terminal domain of SGLTs, a
stretch of 60 amino acids contains the longest stretch
of divergent sequences. We found the same pattern of
sequence conservation at this C-terminal region as at
the N-terminus. SGLT2 displayed the least homology
with the other members of SGLT family, while SGLT1
was more homologous to SGLT3-b than to SGLT3-a.
Figure 5 also shows that, while SGLT2 remains diver-
gent, the sequences of the last 30 amino acids of SGLT1
and SGLT3 isoforms exhibit a high level of identity.
Amino acid comparison of mouse, pig, and human
SGLT3 sequences
In addition to the predicted mRNA sequences of
mouse Slc5a4a and Slc5a4b genes, only a hand-full of
SGLT3 cDNA sequences have been reported so far.
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Fig. 5. Amino acid comparison of the four mouse kidney sodium-glucose cotransporters (SGLTs). Amino acid sequences of SGLT1, SGLT2, and
SGLT3-b were deduced from their respective mouse kidney cDNA sequences (this study and [15]). Amino acids 1 to 450 of Slc5a4a were added
to our partial SGLT3-a to complete the sequence. Sequences were aligned using PileUp program of SeqWeb at default settings. Shaded amino
acids represent identical residues in all four SGLTs. Gaps in the sequences were indicated by dots. Conserved residues with known functional
roles are indicated by a *. The regions of sequence divergence are indicated by a line above the sequence. Sequences were analyzed by NetNGlyc
1.0 at www.cbs.dtu.dk for prediction of glycosylation sites. Boxed Asn residues at position 248 in all four SGLTs were predicted to be N-linked
glycosylated. Numbers to the right correspond to the position of residue in respective SGLT amino acid sequence.
Full-length cDNA sequences of SGLT3 include those
isolated from mouse kidney (SGLT3-b, this study), the
pig LLC-PK1 cell line [3], and human small intestine with
the GenBank accession number AJ133127. Figure 6
shows the alignment of the full-length amino acid se-
quences of the above SGLT3s. More than 80% similarity
was observed throughout the length of these SGLT3
sequences. Interestingly, the lowest similarity (82%) was
between the two mouse SGLT3 isoforms and each had
a higher degree of sequence homology with other mem-
bers of SGLT3. The highest level of sequence homology,
88%, was between pig and human. Like the pattern ob-
served among the four members of SGLT family (Fig. 5),
the major regions of sequence divergence among SGLT3s
were also the N- and C-terminal portions of these se-
quences (Fig. 6). The divergent sequences at the N-termi-
nal domain included the first 24 amino acids with the
exception of the first four residues. The longest divergent
region of SGLT3s again appeared to be at the C-terminal
domain and included about 60 amino acids correspond-
ing to E577 through K627 of pig SGLT3. A major gap
of four residues corresponding to the pig Q624 through
K627 was observed in the sequence of Slc5a4a. The por-
tion of Slc5a4a amino acid sequence containing this gap
was identical to our partial cDNA sequence of SGLT3-a
(Fig. 3). The terminal 30 amino acids of SGLT3s show
high level of sequence conservation.
DISCUSSION
Chronic exposure to cadmium has been associated with
impaired uptake of essential nutrients from glomerular
filtrate and the development of the acquired Fanconi
syndrome [17–19]. To elucidate the mechanism by which
cadmium might cause this syndrome, it is essential to
study the effect of this metal on the different components
responsible for glucose transport in the proximal renal
tubule epithelium. The accepted model for glucose reab-
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Fig. 6. Amino acid comparison of mouse, pig and human sodium-glucose cotransporter SGLT3. Amino acid sequences of SGLT3-a and SGLT3-b
are the same as Fig. 5 and the cDNA sequences of pig and human SGLT3s were from LLC-PK1 cells and small intestine, respectively. Sequences
were aligned using Pretty program of SeqWeb with default settings. A consensus sequence was obtained from the alignment when at least two
SGLT3s had the same residue at a particular position in the sequence. Consensus is shown in bold and dashes indicate identical residues to the
consensus sequence. A  in the consensus sequence represents two pairs of identical residues or lack of sequence identity. Gaps in the sequences
were indicated by dots. The regions of sequence divergence are indicated by a line above the sequence.
sorption by proximal tubule cells involves SGLT1 and
SGLT2. However, with the identification of SGLT3, the
presumed exclusive roles of SGLT1 and SGLT2 in glu-
cose reabsorption may require modification.
Both human and mouse SGLT3 genes have been
mapped to chromosomes. Human SGLT3 is encoded by
single gene located on chromosome 22 [20]. However,
mouse has two SGLT3 genes, Slc5a4a and Slc5a4b, which
are on opposite strands of chromosome 10, and are ap-
proximately 37 kb apart [5]. This study shows for the
first time that in mouse kidney both Slc5a4a and Slc5a4b
genes are transcribed. We identified an adenine nucleo-
tide at position 1771 of SGLT3-b cDNA clone, which
was absent from that of Slc5a4b [5]. Our revised deduced
amino acid sequence of SGLT3-b (encoded by Slc5a4b)
now includes additional 44 amino acids at the C-terminus
to a total of 660 residues. Mouse SGLT3 isoforms show
high degree of sequence homology with that of pig and
human sequences. While pig SGLT3 has been isolated
from kidney cell line, the human SGLT3, as well as
several mice partial cDNA sequences, have been isolated
from small intestine. In addition to kidney and small
intestine, a partial SGLT3 cDNA fragment has been
isolated from human brain [21]. RT-PCR and hybridiza-
tion analyses have suggested that SGLT3 mRNA is pres-
ent in human carcinomas from kidney, colon, and ovary
[19]. Such evidence for expression of SGLT3 mRNA in
multiple organs may suggest an important physiologic
role of SGLT3 in transport of essential nutrients.
When secondary structures of the mouse SGLT3s
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were compared, it appeared that both shared the same
predicted membrane topology (Fig. 4B). Turk and
Wright [23] had also suggested the same topology for
the members of SGLT1 and for the pig SGLT3. In addi-
tion to the similarity in the predicted secondary struc-
tures of SGLTs, the length and position of each predicted
domain appear to be highly conserved. The N- and the
C-terminal regions of the mouse SGLTs are the most
divergent regions. The largest region of sequence diver-
gence includes about 60 amino acids and is located en-
tirely in the cytoplasm. Overall, SGLT2 appears to be
the least homologous of the four SGLTs, especially at
its N-terminus where homology to other SGLTs is com-
pletely lacking. SGLT1 is more homologous to SGLT3-b
than to SGLT3-a.
In SGLT1, the N-terminal portion of the protein has
been shown to be involved in Na translocation and
sugar interaction while the C-terminus plays a role in
sugar binding and translocation [24]. Several studies have
addressed the functional role of specific residues in
SGLT1. Among the residues studied, A166 and K321
have been shown both to play crucial roles in Na bind-
ing and Na/sugar transport [25–27]. The two residues
are conserved among the four mouse SGLTs. However,
the region containing K321 appeared to be more con-
served than the region of A166. TMHs 10 to 13 of SGLT1
were suggested to form the sugar-binding/translocation
domain of this protein [24]. In mouse SGLT sequences,
this region is located between corresponding L422 to
T548 of SGLT3-a and is relatively conserved (Fig. 5).
Within this region, the importance of SGLT1 residues
Q457, A468, and R499 in translocation of sugar has
also been suggested. However, amino acid alignment of
SGLTs showed that only R499 of SGLT1 was conserved
in the other SGLTs (Fig. 5). In addition to the above
residues with roles in sugar transport, R427 was sug-
gested to play a role in membrane localization of SGLT1
since immunocytochemical analysis of R427A SGLT1
showed that this mutant protein was incorrectly localized
underneath the plasma membrane [28]. This residue is
also conserved among the four SGLTs, while the sur-
rounding residues do not show significant conservation.
In vitro, rabbit SGLT1 has been shown to be N-glycosy-
lated at N248 [29]. Our analysis of mouse SGLT3 se-
quences also predicts the same position of N-linked gly-
cosylation in a region of little sequence conservation
(Fig. 5).
Without recognition of the extremely high level of
sequence identity among the SGLT family of proteins
and their respective topologies, studies on expression of
these proteins could be misleading. A polyclonal anti-
body raised against rabbit SGLT1 peptide 402-STLFTM
DIYTKIRKKASEK-420 had been used in expression
analysis of SGLT1 in brain [21, 30]. Western blot analysis
of pig brain with this SGLT1 antibody showed that it
was nonspecific and cross-reacted with more than one
protein. Since the same study showed that pig brain ex-
pressed mRNA of SGLT3, it was concluded that this anti-
body could have cross-reacted with SGLT3. Garriga et al
[31] used the same SGLT1 antibody (peptide 402-420) to
study the expression of SGLT1 in the chicken intestine.
They too found that this antibody cross-reacted with
more than one protein in the brush-border membrane
of chicken intestine. In addition, these investigators also
used an antibody against the rabbit SGLT1 peptide 564-
RNSKEERIDLDA-575 and showed that this antibody
recognized a single 75 kD brush-border membrane pro-
tein. They concluded that this antibody specifically de-
tected SGLT1. The amino acid comparison presented
in Figure 5 clearly demonstrates that the amino acid
sequences of both antigen peptides were highly con-
served among the SGLTs. The conclusion regarding the
specificity of the SGLT1 564-575 peptide antibody may
be further questioned since it has been recently shown
that cDNA of SGLT3 was present in small intestine of
mice and human (see above). In addition to polyclonal
antibodies against peptide antigens, several monoclonal
antibodies have also been described [32, 33]. These mono-
clonal antibodies were raised against pools of membrane
proteins, and most recognized more than one protein in
kidney brush-border membrane. In addition to high level
of sequence identity among SGLTs, the issue of raising
specific antibodies to any pools of membrane proteins
is further complicated by the fact that all SGLTs have
the same predicted molecular weight of 72 to 73 kD and
potentially could be copurified.
In our in vitro study of inhibitory effect of cadmium
on glucose uptake by cultured mouse kidney cortical
cells, we had shown that these cells expressed mRNA
of SGLT1, SGLT2, and SGLT3-b. We demonstrated that
cadmium’s inhibitory effect on glucose uptake coincided
with a decrease in the mRNA levels of SGLT1 and
SGLT2. On the other hand, the mRNA of SGLT3-b was
significantly increased in cells exposed to the same concen-
trations of cadmium. With an increase in mRNA level
of SGLT3-a in response to 5 to 10 mol/L cadmium,
the effect of this metal on SGLT3-a resembled that of
SGLT3-b. Our observed effect of cadmium on mRNA
levels of SGLTs may involve modulation of transcription
of their respective genes, or an effect of this metal ion
on mRNA stability. We are currently investigating these
two possibilities in modulation of SGLT1 mRNA in re-
sponse to cadmium.
Pig SGLT3, when expressed in Xenopus oocytes, is able
to specifically stimulate sodium-dependent concentrative
uptake of the d-glucose conjugate of isophosphoramide
mustard, (D-19575). However, neither rabbit SGLT1 nor
human SGLT2 was able to confer the ability to transport
this substrate into Xenopus oocytes [22]. We attempted
to measure uptake of D-19575 in cultures of untreated
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and 5 mol/L cadmium-treated mouse kidney cortical
cells to determine whether the changes in SGLT3 mRNA
led to an increase in specific substrate transport. Unfortu-
nately, sodium-dependent uptake of D-19575 in un-
treated cultures was very low, approximately 6% of the
uptake of AMG, and after cadmium exposure did not
increase significantly (data not shown, N  3). Because
D-19575 is so poorly transported into mouse kidney cells,
it is difficult to draw conclusions about the lack of effect
of cadmium on the process from these results.
The ability to induce SGLT3-a and SGLT3-b mRNA
in cells exposed to cadmium provides a valuable tool to
investigate the nature of glucose uptake in the kidneys.
The observed molecular response to cadmium may be
indicative of a complementary transport activity of SGLT3
isoforms in kidney and their compensatory role in condi-
tions under which normal uptake of glucose is compro-
mised.
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